BOTZ vs IBB
Global X Robotics & Artificial Intelligence ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.68% for BOTZ.
- • BOTZ pays a higher dividend yield (0.47%).
Side-by-side metrics
| Metric | BOTZ | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.68% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.47% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $3.52B | $9.09B |
YTD return | -0.61% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.81 | 0.69 |
P/E ratio | 35.96 | 24.79 |
Last price | $36.66 | $196.62 |
Inception | — | — |
Issuer | Global X | iShares |
BOTZ top holdings
| 6861.T | Keyence Corp | 9.77% |
| ABBN.SW | ABB Ltd | 9.71% |
| 6954.T | Fanuc Corp | 8.69% |
| NVDA | NVIDIA Corp | 8.31% |
| ISRG | Intuitive Surgical Inc | 6.10% |
| 6273.T | SMC Corp | 4.29% |
| 300124.SZ | Shenzhen Inovance Technology Co Ltd Class A | 4.09% |
| 6383.T | Daifuku Co Ltd | 3.56% |
| 300757.SZ | RoboTechnik Intelligent Technology Co Ltd Class A | 2.79% |
| CGNX | Cognex Corp | 2.56% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About BOTZ
BOTZ (Global X Robotics & Artificial Intelligence ETF) is Robotics, automation, and AI companies globally. Managed by Global X, the fund carries $3.5B in assets under management, an expense ratio of 0.68%, a dividend yield of 0.47%. Its largest holding is Keyence Corp (6861.T), which represents 9.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.2%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.